Here's What Key Metrics Tell Us About Addus HomeCare (ADUS) Q4 Earnings

Core Insights - Addus HomeCare (ADUS) reported revenue of $297.14 million for the quarter ended December 2024, reflecting a year-over-year increase of 7.5% and a surprise of +1.71% over the Zacks Consensus Estimate of $292.16 million [1] - The company's EPS for the quarter was $1.38, which is an increase from $1.32 in the same quarter last year, aligning with the consensus EPS estimate [1] Revenue Breakdown - Personal Care revenue reached $220.33 million, exceeding the average estimate of $203.82 million by two analysts, representing a year-over-year change of +7.7% [4] - Home Health revenue was reported at $17.83 million, slightly above the average estimate of $17.29 million, marking a +4.1% year-over-year increase [4] - Hospice revenue totaled $58.99 million, surpassing the estimated $58.01 million, with a year-over-year change of +7.8% [4] Stock Performance - Over the past month, Addus HomeCare shares have returned -16.4%, compared to a -0.5% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]